FlexGen is an innovative biotech company based in Leiden, the Netherlands. FlexGen is a spin-off from Leiden University Medical Centre (LUMC) and Dutch Space (part of EADS) and has proprietary technologies for laser based in-situ synthesis of oligonucleotides and other biomolecules. FlexGen commercializes the FlexArrayer, a bench-top instrument for custom microarray and oligopool synthesis. FlexGen works at the forefront of innovative microarray and oligopool applications.
Looking for a particular FlexGen B.V. employee's phone or email?
The FlexGen B.V. annual revenue was $5.1 million in 2026.
Hans van Rosendael is the CFO of FlexGen B.V..
2 people are employed at FlexGen B.V..
The NAICS codes for FlexGen B.V. are [5417, 541, 54, 541713, 54171].
The SIC codes for FlexGen B.V. are [873, 87].